These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35075805)

  • 1. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
    Yuan B; Zhao X; Wang X; Liu E; Liu C; Zong Y; Jiang Y; Hou M; Chen Y; Chen L; Zhang Y; Wang H; Fu J
    Clin Transl Med; 2022 Jan; 12(1):e678. PubMed ID: 35075805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.
    Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T
    Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
    Wu H; Wang W; Zhang Y; Chen Y; Shan C; Li J; Jia Y; Li C; Du C; Cai Y; Zhang Y; Zhang S; Wu F
    Int J Cancer; 2024 Jul; 155(2):324-338. PubMed ID: 38533706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing.
    Feng F; Cheng Q; Yang L; Zhang D; Ji S; Zhang Q; Lin Y; Li F; Xiong L; Liu C; Jiang X
    Oncotarget; 2017 Jan; 8(3):5349-5360. PubMed ID: 28029662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized
    Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
    Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
    Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H
    J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
    Zhang Y; Zuo C; Liu L; Hu Y; Yang B; Qiu S; Li Y; Cao D; Ju Z; Ge J; Wang Q; Wang T; Bai L; Yang Y; Li G; Shao Z; Gao Y; Li Y; Bian R; Miao H; Li L; Li X; Jiang C; Yan S; Wang Z; Wang Z; Cui X; Huang W; Xiang D; Wang C; Li Q; Wu X; Gong W; Liu Y; Shao R; Liu F; Li M; Chen L; Liu Y
    J Hepatol; 2021 Nov; 75(5):1128-1141. PubMed ID: 34171432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.
    Calandrini C; Schutgens F; Oka R; Margaritis T; Candelli T; Mathijsen L; Ammerlaan C; van Ineveld RL; Derakhshan S; de Haan S; Dolman E; Lijnzaad P; Custers L; Begthel H; Kerstens HHD; Visser LL; Rookmaaker M; Verhaar M; Tytgat GAM; Kemmeren P; de Krijger RR; Al-Saadi R; Pritchard-Jones K; Kool M; Rios AC; van den Heuvel-Eibrink MM; Molenaar JJ; van Boxtel R; Holstege FCP; Clevers H; Drost J
    Nat Commun; 2020 Mar; 11(1):1310. PubMed ID: 32161258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
    Li J; Xu H; Zhang L; Song L; Feng D; Peng X; Wu M; Zou Y; Wang B; Zhan L; Hua G; Zhan X
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2637-2647. PubMed ID: 31598791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
    Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
    J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
    Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
    BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
    Lu K; Feng F; Yang Y; Liu K; Duan J; Liu H; Yang J; Wu M; Liu C; Chang Y
    J Gastroenterol; 2020 Jan; 55(1):51-66. PubMed ID: 31562534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
    Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
    Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The establishment of kidney cancer organoid line in drug testing.
    Tse RT; Wong CY; Ding X; Cheng CK; Chow C; Chan RC; Ng JH; Tang VW; Chiu PK; Teoh JY; Wong N; To KF; Ng CF
    Cancer Med; 2024 Jun; 13(12):e7432. PubMed ID: 38923304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
    Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
    J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived renal cell carcinoma organoids for personalized cancer therapy.
    Li Z; Xu H; Yu L; Wang J; Meng Q; Mei H; Cai Z; Chen W; Huang W
    Clin Transl Med; 2022 Jul; 12(7):e970. PubMed ID: 35802820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.